Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuropeptides in human brain--postmortem studies.

J E Kleinman, J Hong, M Iadarola

    Progress in Neuro-Psychopharmacology & Biological Psychiatry
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Fine mapping of PTSD GWAS reveals a role for amygdala <i>Foxp2</i> in regulation of fear and threat responses.

    bioRxiv : the preprint server for biology·2026
    Same author

    Genetic vulnerability to DUSP22 promoter hypermethylation is involved in the relation between in utero famine exposure and schizophrenia.

    NPJ schizophrenia·2018
    Same author

    Longitudinal analyses of the DNA methylome in deployed military servicemen identify susceptibility loci for post-traumatic stress disorder.

    Molecular psychiatry·2017
    Same author

    GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia.

    Molecular psychiatry·2017
    Same author

    Investigating the neuroimmunogenic architecture of schizophrenia.

    Molecular psychiatry·2017
    Same author

    Altered expression of histamine signaling genes in autism spectrum disorder.

    Translational psychiatry·2017
    Same journal

    Single Ayahuasca administration attenuates alcohol relapse and associated behavioral, neurochemical, and oxidative alterations in rats.

    Progress in neuro-psychopharmacology & biological psychiatry·2026
    Same journal

    Altered dorsal striatal subregional connectivity associated with distinct executive function deficits in first-episode, drug-naïve major depressive disorder: Evidence from functional connectivity and granger causality analysis.

    Progress in neuro-psychopharmacology & biological psychiatry·2026
    Same journal

    Chronic pain and stress: unravelling the common neuroinflammatory, immune and endocrine mechanisms for novel therapeutic approaches.

    Progress in neuro-psychopharmacology & biological psychiatry·2026
    Same journal

    Predicting anhedonia and negative cognitive processing changes after 8-week SSRIs treatment in depression from individual differential structural covariance network.

    Progress in neuro-psychopharmacology & biological psychiatry·2026
    Same journal

    Mapping intrinsic neural timescale alterations in major depressive disorder.

    Progress in neuro-psychopharmacology & biological psychiatry·2026
    Same journal

    Probiotics in reducing negative symptoms of schizophrenia: A systematic review and meta-analysis.

    Progress in neuro-psychopharmacology & biological psychiatry·2026
    See all related articles

    Methionine-enkephalin levels were lower in the brains of chronic paranoid schizophrenic patients compared to controls. This suggests a potential role for this neuropeptide in schizophrenia pathology.

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Biochemistry

    Background:

    • Neuropeptides are crucial signaling molecules in the brain.
    • Schizophrenia is a complex mental illness with poorly understood neurobiological underpinnings.
    • Previous research suggests alterations in neurotransmitter systems in schizophrenia.

    Purpose of the Study:

    • To investigate the concentrations of four key neuropeptides in specific brain regions of individuals with mental illness.
    • To explore potential correlations between neuropeptide levels and schizophrenia.
    • To assess the impact of neuroleptic medication on neuropeptide concentrations.

    Main Methods:

    • Radioimmunoassays were employed to quantify substance P, methionine-enkephalin, neurotensin, and cholecystokinin.

    Related Experiment Videos

  • Neuropeptide levels were measured in various brain regions obtained from deceased patients and control subjects.
  • Statistical comparisons were made between patient groups and control groups.

    • Main Results:

    • Significantly reduced concentrations of methionine-enkephalin were observed in the caudate nuclei of chronic paranoid schizophrenic patients.
    • No significant effects of neuroleptic medication were detected on the measured neuropeptide levels.
    • Variations in other neuropeptides were not as pronounced or consistent across groups.

    Conclusions:

    • The findings support the hypothesis that methionine-enkephalin may play a role in the pathophysiology of schizophrenia.
    • Reduced methionine-enkephalin in the caudate nucleus could be a contributing factor to schizophrenic symptoms.
    • Further research is warranted to elucidate the precise mechanisms involving methionine-enkephalin in schizophrenia.